Optimising prenatal diagnosis of Down's syndrome

M. A. Hulton, Ala Szczepura

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Following an editorial in the BMJ on optimising prenatal diagnosis of Down’s syndrome (1), a recent report by Dhallan et al (2) on the potential for risk-free prenatal diagnosis of Down’s syndrome (DS) by the use of maternal blood samples alone has attracted much media attention. There have also recently been a number of other reports (3,4) indicating that this might soon become a viable alternative to current prenatal diagnosis, where unfortunately amniocentesis and chorionic villus sampling (CVS) are associated with a fetal loss rate of around 0.5-1%.
Original languageEnglish
Issue number433
Publication statusPublished - 7 Feb 2007

Bibliographical note

The full text is available from: http://dx.doi.org/10.1136/bmj.332.7539.433


Dive into the research topics of 'Optimising prenatal diagnosis of Down's syndrome'. Together they form a unique fingerprint.

Cite this